Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Kyobu Geka ; 68(6): 406-9, 2015 Jun.
Article in Japanese | MEDLINE | ID: mdl-26066868

ABSTRACT

A 61-year-old man with right lung cancer underwent right lower lobectomy. He suffered from postoperative broncho-pleural fistula, which was treated with thoracic drainage. After disappearance of air leakage, a drainage tube was removed. Forty days later, severe back pain, cough and fever were observed. Chest computed tomography showed enlarged thoracic cavity around the bronchial stump. Bronchoscopical examination revealed complete dehiscence of the bronchial stump. Because thoracic cavity was localized and located dorsal to the bronchial stump, a fenestration surgery was difficult. We placed a nasal airway from the dorsal to directly thoracic cavity, followed by disappearance of the symptoms. Thoracic cavity around the bronchial stump was gradually decreased and a nasal airway was successfully removed. Because a nasal airway was soft enough to keep supine position, we chose it as a drainage tube. Thoracic drainage using nasal airway may be a suitable therapeutic approach for localized small thoracic cavity.


Subject(s)
Bronchial Fistula/therapy , Drainage , Lung Neoplasms/surgery , Pleural Diseases/therapy , Postoperative Complications/therapy , Bronchial Fistula/etiology , Humans , Male , Middle Aged , Tomography, X-Ray Computed
2.
Gen Thorac Cardiovasc Surg ; 63(7): 379-85, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25802123

ABSTRACT

OBJECTIVES: Surgical reconstruction is commonly recommended for the treatment of tuberculous airway stenosis. The clinical conditions underlying tuberculous airway stenosis often involve both cicatricial stenosis and malacia. Surgical reconstruction alone may not improve the respiratory symptoms of patients with both types of airway stenosis. This study retrospectively reviewed patients who underwent surgical reconstruction for tuberculous airway stenosis to investigate the most appropriate treatment for this complicated condition. METHODS: Twelve patients with tuberculous airway stenosis underwent surgical reconstruction at our institute from January 2003 to December 2013. The clinical courses of these patients were retrospectively reviewed. RESULTS: The 12 patients were 2 men and 10 women with a mean age of 36 years (range 17-61 years). The site of stenosis was the left main bronchus in six patients, trachea in four patients, and right main bronchus in two patients. The procedure performed was sleeve lobectomy in five patients, bronchial resection in four patients, and tracheal resection in three patients. Additional airway stenting was performed in two patients with concomitant malacia of the lower trachea. The performance status and Hugh-Jones classification improved postoperatively in all patients. The forced expiratory volume in 1 s as a percent of forced vital capacity and percent of forced expiratory volume in 1 s improved significantly. CONCLUSION: Surgical reconstruction is an acceptable treatment for tuberculous airway stenosis. Additional airway stenting may be needed in patients with symptomatic malacia.


Subject(s)
Tracheomalacia/surgery , Tuberculosis, Pulmonary/complications , Adolescent , Adult , Constriction, Pathologic/complications , Constriction, Pathologic/surgery , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Plastic Surgery Procedures/methods , Retrospective Studies , Stents , Tracheomalacia/complications , Treatment Outcome , Young Adult
3.
Ann Thorac Cardiovasc Surg ; 21(2): 114-8, 2015.
Article in English | MEDLINE | ID: mdl-25273272

ABSTRACT

PURPOSE: Malignant airway stenosis extending from the bronchial bifurcation to the lower lobar orifice was treated with airway stenting. We herein examine the effectiveness of airway stenting for extensive malignant airway stenosis. METHODS: Twelve patients with extensive malignant airway stenosis underwent placement of a silicone Dumon Y stent (Novatech, La Ciotat, France) at the tracheal bifurcation and a metallic Spiral Z-stent (Medico's Hirata, Osaka, Japan) at either distal side of the Y stent. We retrospectively analyzed the therapeutic efficacy of the sequential placement of these silicone and metallic stents in these 12 patients. RESULTS: The primary disease was lung cancer in eight patients, breast cancer in two patients, tracheal cancer in one patient, and thyroid cancer in one patient. The median survival period after airway stent placement was 46 days. The Hugh-Jones classification and performance status improved in nine patients after airway stenting. One patient had prolonged hemoptysis and died of respiratory tract hemorrhage 15 days after the treatment. CONCLUSION: Because the initial disease was advanced and aggressive, the prognosis after sequential airway stent placement was significantly poor. However, because respiratory distress decreased after the treatment in most patients, this treatment may be acceptable for selected patients with extensive malignant airway stenosis.


Subject(s)
Airway Obstruction/therapy , Breast Neoplasms/complications , Bronchoscopy/instrumentation , Stents , Thoracic Neoplasms/complications , Tracheal Stenosis/therapy , Adult , Aged , Airway Obstruction/diagnosis , Airway Obstruction/etiology , Airway Obstruction/mortality , Breast Neoplasms/diagnosis , Breast Neoplasms/mortality , Bronchoscopy/adverse effects , Constriction, Pathologic , Female , Humans , Kaplan-Meier Estimate , Male , Metals , Middle Aged , Palliative Care , Prosthesis Design , Retrospective Studies , Silicones , Thoracic Neoplasms/diagnosis , Thoracic Neoplasms/mortality , Time Factors , Tomography, X-Ray Computed , Tracheal Stenosis/diagnosis , Tracheal Stenosis/etiology , Tracheal Stenosis/mortality , Treatment Outcome
4.
Ann Thorac Cardiovasc Surg ; 20 Suppl: 482-5, 2014.
Article in English | MEDLINE | ID: mdl-24200657

ABSTRACT

There are few reports of resected cases of second primary lung cancer in post-treatment survivors of small-cell lung cancer. Here, we report a surgical case of a 62-year-old female with second primary lung adenocarcinoma after chemoradiotherapy against small-cell lung cancer. She had been treated for small-cell lung cancer 2 years earlier, and achieved complete response after the treatment. A new nodular lesion was detected at a different segment in the right lower lobe. We performed a right lower lobectomy accompanied with systemic mediastinal nodal dissection. Histopathological findings revealed that the new nodular lesion was a second primary lung adenocarcinoma. No metastatic tumor was seen in the dissected lymph node; the initial tumor had disappeared completely. The postoperative course was uneventful, and she was discharged on day 10 after the operation. Ten months after the operation, she was free of recurrent tumor.


Subject(s)
Adenocarcinoma/therapy , Lung Neoplasms/therapy , Neoplasms, Multiple Primary/therapy , Small Cell Lung Carcinoma/therapy , Adenocarcinoma/pathology , Chemoradiotherapy , Female , Humans , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Lymphatic Metastasis , Middle Aged , Neoplasms, Multiple Primary/pathology , Neoplasms, Multiple Primary/surgery , Pneumonectomy , Small Cell Lung Carcinoma/pathology
5.
Ann Thorac Cardiovasc Surg ; 18(3): 243-6, 2012.
Article in English | MEDLINE | ID: mdl-22790998

ABSTRACT

Wedge resection for tissue diagnosis of indeterminate lung tumors that is strongly suspected of being lung cancer, is sometimes difficult, and lobectomy, followed by a thorough pathological examination, is required. In the present report, four cases are presented, and the following indications, which have never been discussed before, are recommended for lobectomy without a pre-resectional diagnosis. First, where larger tumors are involved, and lobectomy is expected to result in a more favorable patient status and second, where the lesions are deeply located near major pulmonary vessels, or the patient is not a candidate for wedge resection or segmental resection. In each case, tolerance to surgery and detailed, informed consent for potentially complete resection are mandatory.


Subject(s)
Carcinoma/surgery , Lung Neoplasms/surgery , Pneumonectomy , Aged , Biomarkers, Tumor/blood , Biopsy , Carcinoma/blood , Carcinoma/pathology , Female , Humans , Lung Neoplasms/blood , Lung Neoplasms/pathology , Male , Middle Aged , Neoplasm Staging , Pneumonectomy/methods , Predictive Value of Tests , Thoracic Surgery, Video-Assisted , Thoracotomy , Tomography, X-Ray Computed , Treatment Outcome , Tumor Burden
6.
Int J Clin Oncol ; 17(3): 250-5, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21748260

ABSTRACT

BACKGROUND: Reactive oxygen species stimulate lymphatic metastasis by accelerating epithelial-to-mesenchymal transition and lymphangiogenesis in the tumor microenvironment. Hence, systemic oxidative stress level may correlate with nodal involvement in patients with a malignant tumor. METHODS: We examined 46 patients with clinical stage I lung adenocarcinoma who had undergone pulmonary resection with mediastinal lymph node dissection. Serum reactive oxygen metabolite (ROM) level was measured as an indicator of systemic oxidative stress. We investigated the association between nodal involvement and clinicopathological factors. RESULTS: Preoperative serum carcinoembryonic antigen (CEA; P = 0.045), cytokeratin 19 fragment (CYFRA21-1; P = 0.038), and ROM (P = 0.007) levels were significantly higher in patients with nodal involvement than in those without nodal involvement. A receiver operating characteristic curve was constructed to determine whether patients with and without nodal involvement could be differentiated on the basis of their serum ROM levels. The area under curve was 0.763 and the prognostic cut-off value was set at 318 Carratelli units. In univariate analysis, clinical stage IB (odds ratio [OR] = 4.55; P = 0.033), CEA-positive (OR = 5.56, P = 0.018), and ROM-positive (OR = 10.46, P = 0.006) were significant predictive factors for nodal involvement. In multivariate analysis, ROM-positive was an independent predictive factor for nodal involvement (OR = 6.22, P = 0.045). CONCLUSION: Preoperative serum ROM level was an independent significant predictive factor for nodal involvement in patients with clinical stage I lung adenocarcinoma. Hence, serum ROM level may be a useful biomarker for staging of lung adenocarcinoma.


Subject(s)
Adenocarcinoma/pathology , Lung Neoplasms/pathology , Oxidative Stress , Reactive Oxygen Species/blood , Adenocarcinoma/metabolism , Adenocarcinoma of Lung , Aged , Aged, 80 and over , Antigens, Neoplasm/blood , Biomarkers/blood , Carcinoembryonic Antigen/blood , Female , Humans , Keratin-19/blood , Lung Neoplasms/metabolism , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging
7.
Gen Thorac Cardiovasc Surg ; 59(5): 335-40, 2011 May.
Article in English | MEDLINE | ID: mdl-21547627

ABSTRACT

PURPOSE: Reactive oxygen species contribute to various features of malignant tumors, including carcinogenesis, aberrant growth, metastasis, and angiogenesis. Investigation of serum oxidative stress levels may predict the tumor's condition, including malignant and metastatic potential. METHODS: We recruited 46 patients (27 men, 19 women; median age 70 years) with clinical stage I lung adenocarcinoma who had undergone pulmonary resection with mediastinal lymph node dissection. Preoperative serum reactive oxygen metabolite (ROM) levels were measured as an indicator of oxidative stress. RESULTS: The serum ROM level was significantly correlated with the increase in tumor size (P = 0.018) and pathological nodal extension (P = 0.005). Multivariate analysis revealed that pathological nodal extension was significantly correlated with the increase in serum ROM level (P = 0.027). The prognostic cutoff value was determined according to receiver operating characteristic curve analysis for patients with and those without nodal extension; the cutoff value was determined to be 318 Carratelli units (U.CARR). CONCLUSION: The findings of our study revealed that patients with clinical stage I lung adenocarcinoma and a serum ROM level above 318 U.CARR were likely to develop nodal extension. The finding of a significant correlation between serum ROM level and nodal extension may help in the development of new treatment strategies.


Subject(s)
Adenocarcinoma/blood , Biomarkers, Tumor/blood , Carcinoma, Non-Small-Cell Lung/blood , Lung Neoplasms/blood , Lymph Nodes/pathology , Oxidative Stress , Reactive Oxygen Species/blood , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Aged , Carcinoma, Non-Small-Cell Lung/secondary , Carcinoma, Non-Small-Cell Lung/surgery , Female , Humans , Japan , Logistic Models , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Lymph Node Excision , Lymphatic Metastasis , Male , Neoplasm Staging , Odds Ratio , Pneumonectomy , Predictive Value of Tests , Preoperative Period , ROC Curve , Risk Assessment , Risk Factors , Treatment Outcome , Tumor Burden , Up-Regulation
8.
Gen Thorac Cardiovasc Surg ; 58(10): 538-41, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20941570

ABSTRACT

Various tumors metastasize to the lung, and they are often detected as multiple nodules. We report on two cases of such multiple lung metastases combined with primary lung cancer: a myxoid liposarcoma in the right thigh and a colon cancer. In each case, a pulmonary metastasectomy revealed that one of the tumors was primary lung cancer. Regardless of recent advances in computed tomography for detecting small pulmonary nodules and ground-glass opacity components, which indicate possible primary lung cancer, the preoperative differential diagnosis for either metastatic or primary lung cancers is usually difficult because they are too small to obtain enough tissue for diagnosis, except by surgery. When nodules are removed and diagnosed as lung metastasis combined with primary lung cancer, additional treatment should be considered depending on the prognosis of each disease.


Subject(s)
Adenocarcinoma, Bronchiolo-Alveolar/pathology , Adenocarcinoma/pathology , Colonic Neoplasms/pathology , Leiomyosarcoma/secondary , Lung Neoplasms/pathology , Multiple Pulmonary Nodules/pathology , Soft Tissue Neoplasms/pathology , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Adenocarcinoma, Bronchiolo-Alveolar/surgery , Aged , Chemotherapy, Adjuvant , Colonic Neoplasms/surgery , Female , Humans , Leiomyosarcoma/surgery , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Middle Aged , Multiple Pulmonary Nodules/surgery , Neoadjuvant Therapy , Neoplasm Staging , Pneumonectomy , Soft Tissue Neoplasms/surgery , Thigh , Thoracic Surgery, Video-Assisted , Tomography, X-Ray Computed , Treatment Outcome
9.
Article in English | MEDLINE | ID: mdl-17102494

ABSTRACT

A model for measuring the quality of nursing care has been developed in Japan since 1993 by Katada. Then a self evaluation model was developed in 2002 by Abe et al. This model consisted of three dimensions: structure, process, and outcome. Each dimension was constructed from measurements of six domains which applicants categorized previously, such as "understanding individuality", "patient empowerment", "family care", "direct care", "medical team coordination", and "incident prevention" In this study, it has been developed and posted on a web site for inspection and examined for its usability.


Subject(s)
Internet , Nursing Care/standards , Quality Assurance, Health Care/organization & administration , Humans , Japan
SELECTION OF CITATIONS
SEARCH DETAIL
...